These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1710385)

  • 1. Noradrenergic mechanisms involved in muscle relaxation: significance for the treatment of spasticity.
    Wiesendanger M; Corboz M; Palmeri A; Chen DF; Palmer CI
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):132-4. PubMed ID: 1710385
    [No Abstract]   [Full Text] [Related]  

  • 2. Spasticity: a review.
    Young RR
    Neurology; 1994 Nov; 44(11 Suppl 9):S12-20. PubMed ID: 7970006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tizanidine and electrophysiologic analysis of spinal control mechanisms in humans with spasticity.
    Delwaide PJ; Pennisi G
    Neurology; 1994 Nov; 44(11 Suppl 9):S21-7; discussion S27-8. PubMed ID: 7970007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the locus coeruleus in the control of paradoxical sleep generation in the cat.
    Sakai K; Crochet S
    Arch Ital Biol; 2004 Jul; 142(4):421-7. PubMed ID: 15493546
    [No Abstract]   [Full Text] [Related]  

  • 5. Spinal and locus coeruleus noradrenergic lesions abolish the analgesic effects of 5-methoxy-N,N-dimethyltryptamine.
    Danysz W; Jonsson G; Minor BG; Post C; Archer T
    Behav Neural Biol; 1986 Jul; 46(1):71-86. PubMed ID: 3015120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and management of tolerance in intrathecal baclofen therapy.
    Heetla HW; Staal MJ; Kliphuis C; van Laar T
    Spinal Cord; 2009 Oct; 47(10):751-6. PubMed ID: 19333246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways.
    Centonze D
    Eur Neurol; 2014; 72 Suppl 1():6-8. PubMed ID: 25278116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of tizanidine in the treatment of spasticity.
    Neurology; 1994 Nov; 44(11 Suppl 9):S1-80. PubMed ID: 7970005
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative profile of tizanidine in the management of spasticity.
    Lataste X; Emre M; Davis C; Groves L
    Neurology; 1994 Nov; 44(11 Suppl 9):S53-9. PubMed ID: 7970011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of spasticity].
    Autti-Rämö I
    Duodecim; 1999; 115(8):877-85. PubMed ID: 11859520
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current data on bipolar disorders, epilepsy and spasticity. 4. Neuro-Forum, Dresden].
    Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Aktuelles):1-12. PubMed ID: 10368778
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-spasticity medications.
    Al-Shahrani AM
    Saudi Med J; 2003 Jan; 24(1):19-22. PubMed ID: 12590267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An approach to switching patients from baclofen to tizanidine.
    Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T
    Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tizanidine for spasticity.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):62-3. PubMed ID: 9217694
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacological management of spasticity.
    Saulino M; Jacobs BW
    J Neurosci Nurs; 2006 Dec; 38(6):456-9. PubMed ID: 17233517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of neurons in locus coeruleus in inhibitory effect on glossopharyngeal expiratory activity in a neonatal rat brainstem-spinal cord preparation in vitro.
    Yamanishi T; Koizumi H; Komaki M; Ishihama K; Adachi T; Enomoto A; Takao K; Iida S; Kogo M
    Neurosci Res; 2008 Jan; 60(1):2-9. PubMed ID: 18053604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group.
    Nance PW; Bugaresti J; Shellenberger K; Sheremata W; Martinez-Arizala A
    Neurology; 1994 Nov; 44(11 Suppl 9):S44-51; discussion S51-2. PubMed ID: 7970010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tizanidine as treatment of spasticity in patients with hemiplegia caused by a CVA or brain injury].
    Weynants L; Van Laere M
    Acta Belg Med Phys; 1990; 13(1):19-22. PubMed ID: 2336897
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of tizanidine.
    Roberts RC; Part NJ; Pokorny R; Muir C; Leslie GC; Emre M
    Neurology; 1994 Nov; 44(11 Suppl 9):S29-31. PubMed ID: 7970008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of a new myorelaxant in neurological affections (author's transl)].
    Chantraine A; Van Ouwenaller C
    J Belge Med Phys Rehabil; 1981; 4(1):5-14. PubMed ID: 7309686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.